Why COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This WeekThe Motley Fool • 08/06/21
Earnings Results: Novavax stock drops as wider-than-expected loss overshadows vaccine booster dataMarket Watch • 08/05/21
Novavax delays Covid vaccine emergency authorization submission to FDA until fourth quarterCNBC • 08/05/21
Novavax Reports Second Quarter 2021 Financial Results and Operational HighlightsPRNewsWire • 08/05/21
Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary VaccinationPRNewsWire • 08/05/21
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 VaccinePRNewsWire • 08/05/21
Europe signs agreement for up to 200 million doses of Novavax's experimental COVID-19 shotMarket Watch • 08/04/21